Sign in
4

Changes in Ownership

Taysha Gene Therapies, Inc. Filed Acc 0001209191-22-023863

Options or other derivatives

  • Chief Financial Officer acquired 40,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Alam Kamran · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-04-06 Grant or award : show line 1 in the form Employee Stock Option (right to buy) +40,000 40,000 D
Loading xslF345X03/doc4.xml…